Australia's Victoria state on Wednesday unveiled plans to develop an onshore messenger-RNA (mRNA) vaccine manufacturing facility and launched three mass coronavirus immunisation centres to speed up ...
Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.
With a little help from the Gates Foundation, Biovac will boost Africa’s vaccine manufacturing capacity with its newly opened ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' the immune system to recog ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Vaccines train the body's defenses to fight infections safely. Learn how vaccines work, how the immune system responds, and ...
ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...
Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...
Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...